2nd Quarter - Report
W STRATEGIES, LLC for GLAXOSMITHKLINE
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013. S. 957: Drug Supply Chain Security Act. S. 959: Pharmaceutical Compounding Quality and Accountability Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.